Health Canada
- Status: approved
PEG-IFN alpha2a or PEG-IFN alpha2b and Ribavirin (PEG-IFN alpha2a or PEG-IFN alpha2b and Ribavirin) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Azienda Ospedaliera V. Cervello is the originator. The local marketing authorisation holder may differ — check the official source linked above.